INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.

Innovita Biological Technology Co., Ltd.

Equities

688253

CNE100005Q14

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-22 EDT			5-day change	1st Jan Change
40.05 ^CNY	-2.55%		-3.21%	+60.14%

04-15	Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-12	China stocks track Asian markets lower on rate concerns	RE

Innovita Biological Technology Co., Ltd. has completed an IPO in the amount of CNY 778.700528 million.

July 21, 2022 at 12:00 am

Innovita Biological Technology Co., Ltd. has completed an IPO in the amount of CNY 778.700528 million.
Security Name: A Shares
Security Type: Common Stock
Securities Offered: 11,663,500
PriceRange: CNY 26.06
Discount Per Security: CNY 1.9545
Security Name: A Shares
Security Type: Common Stock
Securities Offered: 18,217,564
PriceRange: CNY 26.06
Discount Per Security: CNY 1.9545

Latest news about Innovita Biological Technology Co., Ltd.

Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-15	CI
China stocks track Asian markets lower on rate concerns	04-12	RE
Innovita Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI
Innovita Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Innovita Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Innovita Biological Technology Co., Ltd.(SHSE:688253) added to Shanghai Stock Exchange Composite Index	23-07-31	CI
Innovita Biological Technology Co., Ltd.(SHSE:688253) added to Shanghai Stock Exchange A Share Index	23-07-31	CI
Certain A Shares of Innovita Biological Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-JUL-2023.	23-07-28	CI
Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Innovita Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-20	CI
Innovita Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Innovita Biological Technology Co., Ltd. has completed an IPO in the amount of CNY 778.700528 million.	22-07-21	CI
Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-07-10	CI

Chart Innovita Biological Technology Co., Ltd.

Duration

Period

Chart Innovita Biological Technology Co., Ltd.

More charts

Company Profile

Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of point-of-care testing (POCT) rapid diagnostic products. The Company's main products include novel coronavirus (2019-nCoV) neutralizing antibody detection kits using colloidal gold, quantum dot fluorescence immunochromatography and chemiluminescence techniques, and respiratory pathogen detection products, such as whole blood respiratory quintuple detection card, influenza virus triple detection card, virus serum quintuple detection card, respiratory pathogen nine indirect immunofluorescence kit, and others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.	+60.14%	752M
BIOMÉRIEUX	-4.27%	12.11B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.87%	8.07B
DIASORIN S.P.A.	+5.32%	5.67B
LANTHEUS HOLDINGS, INC.	+30.19%	5.48B
AUTOBIO DIAGNOSTICS CO., LTD.	-9.89%	4.12B
10X GENOMICS, INC.	-59.04%	2.75B
ANDON HEALTH CO., LTD.	+8.97%	2.62B
VITROLIFE AB	-4.37%	2.33B
MYRIAD GENETICS, INC.	+21.89%	2.11B

Diagnostic & Testing Substances